Very recently, adiponectin was shown to increase the motility of human prostate cancer [70] and chondrosarcoma cells [71] via a transcriptional upregulation of integrins and activations of p38, AMPK, and NFκB-cascades. This evidence concerns the gene ADIPOQ and Familial prostate cancer.